By expenditures
| Name | Title | Type |
|---|---|---|
| Marilyn Lappin | DIRECTOR OF FINANCE | Auditee |
| Kaleb Lilly | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 323665 | 2024 | 2024-10-02 | Rubinbrown LLP | $602.51M |
| 2908 | 2023 | 2023-11-13 | Rubinbrown LLP | $797.03M |
| 30197 | 2022 | 2022-10-12 | Rubinbrown LLP | $824.82M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 2908 | 2023 | 2023-11-13 | 578115 | 2023-003 | - | - | B |
| 2908 | 2023 | 2023-11-13 | 578114 | 2023-002 | Material Weakness | Yes | B |
| 2908 | 2023 | 2023-11-13 | 578113 | 2023-001 | Material Weakness | Yes | B |
| 2908 | 2023 | 2023-11-13 | 578112 | 2023-001 | Material Weakness | Yes | B |
| 2908 | 2023 | 2023-11-13 | 1673 | 2023-003 | - | - | B |
| 2908 | 2023 | 2023-11-13 | 1672 | 2023-002 | Material Weakness | Yes | B |
| 2908 | 2023 | 2023-11-13 | 1671 | 2023-001 | Material Weakness | Yes | B |
| 2908 | 2023 | 2023-11-13 | 1670 | 2023-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 607414 | 2022-003 | Significant Deficiency | - | L |
| 30197 | 2022 | 2022-10-12 | 607413 | 2022-002 | Material Weakness | Yes | BE |
| 30197 | 2022 | 2022-10-12 | 607412 | 2022-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 607411 | 2022-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 607410 | 2022-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 30972 | 2022-003 | Significant Deficiency | - | L |
| 30197 | 2022 | 2022-10-12 | 30971 | 2022-002 | Material Weakness | Yes | BE |
| 30197 | 2022 | 2022-10-12 | 30970 | 2022-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 30969 | 2022-001 | Material Weakness | Yes | B |
| 30197 | 2022 | 2022-10-12 | 30968 | 2022-001 | Material Weakness | Yes | B |